Tag: GDP

Strengthening System Access Controls During Upgrades: An Inspection-Ready Playbook Pharmaceutical manufacturers frequently confront challenges when upgrading electronic systems. A particularly critical issue arises when system access controls are weak during…

Handling Incomplete ERES Controls During Inspection Walkthroughs: A Comprehensive Playbook The pharmaceutical industry is under increasing scrutiny for the management of Electronic Records and Electronic Signatures (ERES). When ERES controls…

Managing Hybrid Paper-Electronic Workflows: Tactics for Compliance During Inspections The increasing integration of hybrid paper-electronic workflows has created new challenges in regulatory compliance. Specifically, 21 CFR Part 11 requirements for…

Implementing Effective Controls to Prevent ERES System Operation Failures The increasing reliance on electronic records and electronic signatures (ERES) in the pharmaceutical industry underscores the importance of robust controls. ERES…

Risk-Based Remediation for Inadequate ERES Controls During System Upgrade In the rapidly evolving landscape of pharmaceutical compliance, the implementation of Electronic Records and Electronic Signatures (ERES) controls during system upgrades…

Managing Uncontrolled Hybrid Paper-Electronic Workflows During Validation Lifecycle As digital transformation accelerates within pharmaceutical manufacturing, uncontrolled hybrid paper-electronic workflows pose significant regulatory compliance risks, particularly concerning 21 CFR Part 11.…

Mitigating Misuse of Electronic Signatures During Inspection Walkthroughs: A Comprehensive Playbook The increasing reliance on electronic signatures in the pharmaceutical sector brings both efficiency and regulatory challenges, particularly during inspection…

Addressing Record Retention Failures during System Operations – A Comprehensive Playbook Record retention failures during system operation pose significant risks to data integrity and compliance within the pharmaceutical industry. These…

Addressing Record Retention Failures During System Operation: An Inspection-Ready Playbook In the pharma manufacturing landscape, record retention failures can lead to significant operational challenges, especially during inspections. These failures can…

Managing Compliance Gaps in Hybrid Paper-Electronic Workflows During an Audit In the evolving landscape of pharmaceutical manufacturing, hybrid paper-electronic workflows pose significant challenges, particularly during compliance audits. When these workflows…

Addressing ERES Control Failures During the Validation Lifecycle to Avoid Part 11 Findings In today’s pharmaceutical landscape, the integrity of electronic records and electronic signatures (ERES) is paramount. Failing to…

Enhancing System Access Controls to Avoid Part 11 Findings During Inspections The integrity of pharmaceutical manufacturing processes heavily relies on stringent system access controls, especially in the context of electronic…